{"id":"https://openalex.org/W1987407100","doi":"https://doi.org/10.1016/s0009-9236(99)90087-5","title":"Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans","display_name":"Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans","publication_year":1999,"publication_date":"1999-06-01","ids":{"openalex":"https://openalex.org/W1987407100","doi":"https://doi.org/10.1016/s0009-9236(99)90087-5","mag":"1987407100","pmid":"https://pubmed.ncbi.nlm.nih.gov/10391671"},"language":"en","primary_location":{"id":"doi:10.1016/s0009-9236(99)90087-5","doi":"https://doi.org/10.1016/s0009-9236(99)90087-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(99)90087-5","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029778884","display_name":"Jules I. Schwartz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J SCHWARTZ","raw_affiliation_strings":["Merck Research Laboratories, Rahway, NJ 07065-0914, USA","Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories, Rahway, NJ 07065-0914, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C CHAN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C CHAN","raw_affiliation_strings":["Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072472948","display_name":"Saurabh Mukhopadhyay","orcid":"https://orcid.org/0000-0003-2072-5386","observed_orcids":["https://orcid.org/0000-0003-2072-5386"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S MUKHOPADHYAY","raw_affiliation_strings":["Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"K MCBRIDE","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K MCBRIDE","raw_affiliation_strings":["Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054655629","display_name":"T JONES","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T JONES","raw_affiliation_strings":["Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010792370","display_name":"Sherilyn Adcock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S ADCOCK","raw_affiliation_strings":["Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"C MORITZ","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C MORITZ","raw_affiliation_strings":["Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083009855","display_name":"Jerris R. Hedges","orcid":"https://orcid.org/0000-0002-9963-8033","observed_orcids":["https://orcid.org/0000-0002-9963-8033"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J HEDGES","raw_affiliation_strings":["Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056996317","display_name":"Kenneth Grasing","orcid":"https://orcid.org/0000-0002-6464-5700","observed_orcids":["https://orcid.org/0000-0002-6464-5700"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K GRASING","raw_affiliation_strings":["Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5096976138","display_name":"D DOBRATZ","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D DOBRATZ","raw_affiliation_strings":["Merck Research Laboratories Rahway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Research Laboratories Rahway","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":10.2357,"has_fulltext":false,"cited_by_count":89,"citation_normalized_percentile":{"value":0.98381295,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"65","issue":"6","first_page":"653","last_page":"660"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11861","display_name":"Thermal Regulation in Medicine","score":0.7271000146865845,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11861","display_name":"Thermal Regulation in Medicine","score":0.7271000146865845,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.266400009393692,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":0.9160000085830688},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9190000295639038},{"id":"https://openalex.org/keywords/fever","display_name":"fever","score":0.7960000038146973},{"id":"https://openalex.org/keywords/antipyretic-activity","display_name":"antipyretic activity","score":0.9340000152587891},{"id":"https://openalex.org/keywords/diclofenac","display_name":"diclofenac","score":0.8659999966621399},{"id":"https://openalex.org/keywords/ibuprofen","display_name":"ibuprofen","score":1.0},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8270000219345093},{"id":"https://openalex.org/keywords/viral-fever","display_name":"viral fever","score":0.7900000214576721},{"id":"https://openalex.org/keywords/cox-1-cox-2-selectivity","display_name":"COX-1/COX-2 selectivity","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.9940389394760132},{"id":"https://openalex.org/C2779826273","wikidata":"https://www.wikidata.org/wiki/Q244408","display_name":"Diclofenac","level":2,"score":0.8729250431060791},{"id":"https://openalex.org/C2779944601","wikidata":"https://www.wikidata.org/wiki/Q186969","display_name":"Ibuprofen","level":2,"score":0.8393876552581787},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.746758759021759},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.710891604423523},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6518895626068115},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6401171088218689},{"id":"https://openalex.org/C2779252780","wikidata":"https://www.wikidata.org/wiki/Q582687","display_name":"Antipyretic","level":3,"score":0.5633584856987},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5255431532859802},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.47940942645072937},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.4745001494884491},{"id":"https://openalex.org/C2909020919","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Prostaglandin-Endoperoxide Synthase","level":4,"score":0.4601619243621826},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.23379278182983398},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.12750211358070374},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0846337378025055},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06577351689338684},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06249690055847168},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001831","descriptor_name":"Body Temperature","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004008","descriptor_name":"Diclofenac","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D007052","descriptor_name":"Ibuprofen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012453","descriptor_name":"Saimiri","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0009-9236(99)90087-5","doi":"https://doi.org/10.1016/s0009-9236(99)90087-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(99)90087-5","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:10391671","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10391671","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W162257389","https://openalex.org/W1016442247","https://openalex.org/W1504486485","https://openalex.org/W1575557511","https://openalex.org/W1587123510","https://openalex.org/W1647648618","https://openalex.org/W1895256094","https://openalex.org/W1964089588","https://openalex.org/W1974026314","https://openalex.org/W1980153282","https://openalex.org/W1981662925","https://openalex.org/W2003464382","https://openalex.org/W2008574207","https://openalex.org/W2009962040","https://openalex.org/W2011218532","https://openalex.org/W2047217018","https://openalex.org/W2049908664","https://openalex.org/W2066074947","https://openalex.org/W2070386995","https://openalex.org/W2080227735","https://openalex.org/W2085023537","https://openalex.org/W2089923844","https://openalex.org/W2108707538","https://openalex.org/W2115530111","https://openalex.org/W2281386564","https://openalex.org/W2317888114","https://openalex.org/W2412742677","https://openalex.org/W2416947154","https://openalex.org/W2800526221"],"related_works":["https://openalex.org/W2073129443","https://openalex.org/W2063356775","https://openalex.org/W2002256906","https://openalex.org/W2054415514","https://openalex.org/W1964949469","https://openalex.org/W2280960965","https://openalex.org/W1984813271","https://openalex.org/W2104023671","https://openalex.org/W1981662925","https://openalex.org/W2063369648"],"abstract_inverted_index":{"Cyclooxygenase":[0],"(COX)":[1],"exists":[2],"as":[3,15,217],"constitutive":[4],"(COX-1)":[5],"and":[6,17,22,35,76,92,146,182,209],"inducible":[7],"(COX-2)":[8],"isoforms.":[9],"Nonsteroidal":[10],"antiinflammatory":[11],"drugs":[12],"(NSAIDs)":[13],"such":[14,216],"ibuprofen":[16],"diclofenac":[18,70,77,93,218],"inhibit":[19],"both":[20],"COX-1":[21],"COX-2.":[23],"The":[24,221],"role":[25],"of":[26,31,41,134,199,239],"COX-2":[27,44,200,230],"in":[28,33,109,152,204,207,236,241],"the":[29,42,80,147,224,229,237],"genesis":[30,238],"fever":[32,113,240],"monkeys":[34,51,208],"humans":[36,210],"was":[37,48,61,107,122,160],"examined":[38],"with":[39,112],"use":[40],"specific":[43],"inhibitor":[45],"rofecoxib.":[46],"Rofecoxib":[47,75],"administered":[49],"to":[50,96,212],"made":[52],"febrile":[53],"by":[54,63,115,201],"6":[55],"microg/kg":[56],"intravenous":[57],"lipopolysaccharide.":[58],"Induced":[59],"pyrexia":[60],"followed":[62],"oral":[64,132,153],"rofecoxib":[65,91,202],"(1":[66],"or":[67,73,144,219],"3":[68,89],"mg/kg),":[69,72],"(3":[71],"vehicle.":[74],"rapidly":[78],"reversed":[79],"elevated":[81],"temperature":[82,121,154],"(P":[83,189],"<":[84,190],".05":[85],"versus":[86,195],"vehicle":[87],"for":[88,124,192],"mg/kg":[90],"at":[94,155],"70":[95],"90":[97],"minutes":[98],"after":[99,158],"dosing).":[100],"A":[101],"single-dose,":[102],"parallel-group,":[103],"double-blind":[104],"randomized":[105],"trial":[106],"conducted":[108],"94":[110],"patients":[111],"caused":[114],"a":[116],"viral-type":[117],"illness.":[118],"Mean":[119],"baseline":[120],"similar":[123],"all":[125],"groups":[126],"(-38.5":[127],"degrees":[128,162,166,169,173,176,180],"C).":[129],"Patients":[130],"received":[131],"doses":[133],"12.5":[135],"mg":[136,139,142],"rofecoxib,":[137,140],"25":[138],"400":[141],"ibuprofen,":[143],"placebo":[145],"mean":[148],"+/-":[149,164,171,178,185],"SE":[150],"change":[151],"4":[156],"hours":[157],"dosing":[159],"-0.97":[161],"C":[163,170,177,184],"0.11":[165,179],"C,":[167,174,181,187],"-1.19":[168],"0.09":[172],"-1.20":[175],"0.01":[183],"0.17":[186],"respectively":[188],".001":[191],"active":[193],"treatments":[194],"placebo).":[196],"Specific":[197],"inhibition":[198],"results":[203],"antipyretic":[205],"activity":[206],"comparable":[211],"dual":[213],"COX-1/COX-2":[214],"inhibitors":[215],"ibuprofen.":[220],"data":[222],"support":[223],"hypothesis":[225],"that":[226,232],"it":[227],"is":[228,233],"isoform":[231],"primarily":[234],"involved":[235],"humans.":[242]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}